A Pharmacologic Approach to Acquired Cystic Fibrosis Transmembrane Conductance Regulator Dysfunction in Smoking Related Lung Disease

BACKGROUND: Mucus stasis in chronic obstructive pulmonary disease (COPD) is a significant contributor to morbidity and mortality. Potentiators of cystic fibrosis transmembrane conductance regulator (CFTR) activity pharmacologically enhance CFTR function; ivacaftor is one such agent approved to treat...

Descripción completa

Detalles Bibliográficos
Autores principales: Sloane, Peter A., Shastry, Suresh, Wilhelm, Andrew, Courville, Clifford, Tang, Li Ping, Backer, Kyle, Levin, Elina, Raju, S. Vamsee, Li, Yao, Mazur, Marina, Byan-Parker, Suzanne, Grizzle, William, Sorscher, Eric J., Dransfield, Mark T., Rowe, Steven M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3387224/
https://www.ncbi.nlm.nih.gov/pubmed/22768130
http://dx.doi.org/10.1371/journal.pone.0039809

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3387224/
https://www.ncbi.nlm.nih.gov/pubmed/22768130
http://dx.doi.org/10.1371/journal.pone.0039809

Ejemplares similares